Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: Randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670

Journal of Psychopharmacology

Volumn 22, Issue 1, 2008, Pages 55-63

  Baldwin, David ^a,d   Hutchison, John ^b   Donaldson, Kirsteen ^b   Shaw, Bob ^b   Smithers, Andrew ^c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Vernalis PLC   (United Kingdom)

^c Profiad Ltd   (United Kingdom)

^d ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

5 HT1A agonist; Placebo controlled study; Sexual dysfunction; SSRI

Indexed keywords

FLUOXETINE; PAROXETINE; PLACEBO; SEROTONIN 1A AGONIST; SEROTONIN 1D AGONIST; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VML 670;

ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PENIS ERECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; SEXUAL DYSFUNCTION; SINGLE DRUG DOSE; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 37749015728     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107078490     Document Type: Article

References (22)

1. American Psychiatric Association (1994) Diagnostic and statistical manual, fourth edition (DSM-IV). American Psychiatric Association, Washington DC
2. Baldwin D.S. (2004) Sexual dysfunction associated with antidepressant drugs. Expert Opinion on Drug Safety 3: 457 - 470
3. Baldwin D.S., Bridgman K., Buis C. (2006) Sexual dysfunction during acute treatment of major depression: double-blind randomised controlled trial of reboxetine versus paroxetine. Journal of Psychopharmacology 20: 91 - 96
4. Bonierbale M., Lancon C., Tignol J. (2003) The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Current Medical Research and Opinion 19: 114 - 124
5. Clayton A.H., Pradko J.F., Croft H.A., Montano C.B., Leadbetter R.A., Bolden-Watson C., Bass K.I., Donahue R.M., Jamerson B.D., Metz A. (2002) Prevalence of sexual dysfunction among newer antidepressants. Journal of Clinical Psychiatry 63: 357 - 366
6. Clayton A.H., Warnock J.K., Kornstein S.G., Pinkerton R., Sheldon-Keller A., McGarvey E. (2004) A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. Journal of Clinical Psychiatry 65: 62 - 67
7. De Battista C., Solvason B., Poirier J., Kendrick E., Loraas E. (2005) A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. Journal of Clinical Psychiatry 66: 844 - 848
8. Fava M., Nurnberg H.G., Seidman S.N., Holloway W., Nicholas S., Tseng L.J., Stecher V.J. (2006) Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry 67: 240 - 246
9. Feiger A.D., Heiser J.F., Shrivastava R.K., Weiss K.J., Smith W.T., Sitsen J M A, Gilbertini M. (2003) Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder. Journal of Clinical Psychiatry 64: 243 - 249
10. Guy W. (1976) ECDEU Assessment manual for psychopharmacology. 218 - 222. National Institute of Mental Health, Rockville, MD
11. Hamilton M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23: 56 - 62
12. Landen M., Eriksson E., Agren H., Fahlen T. (1999) Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. Journal of Clinical Psychopharmacology 19: 268 - 271
13. McGahuey C.A., Gelenberg A.J., Laukes C.A., Moreno F.A., Delgado P.L., McKnight K.M., Manber R. (2000) The Arizona Sexual Experience Scale (ASEX). reliability and validity. Journal of Sexual and Marital Therapy 26: 25 - 40
14. Michelson D., Bancroft J., Targum S., Kim Y., Tepner R. (2000) Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacological intervention. American Journal of Psychiatry 157: 239 - 243
15. Michelson D., Kociban K., Tamura R., Morrison M.F. (2002) Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. Journal of Psychiatric Research 36: 147 - 152
16. Montejo A.L., Llorca G., Izquierdo J.A., Rico-Villademoros F. (2001) Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Journal of Clinical Psychiatry 62 (Suppl 3). 10 - 21
17. Norden M.J. (1994) Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Depression 2: 109 - 112
18. Nurnberg H.G., Gelenberg A., Hargreave T.B., Harrison W.M., Siegel R.L., Smith M.D. (2001) Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. American Journal of Psychiatry 158: 1926 - 1928
19. Nurnberg H.G., Hensley P.L. (2003) Sildenafil citrate for the management of antidepressant-associated erectile dysfunction. Journal of Clinical Psychiatry 64 (Suppl 10). 20 - 25
20. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.). the development and validation of a structured diagnostic interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59: 22 - 33
21. Williams V S L, Baldwin D.S., Hogue S., Fehnel S.E., Hollis K., Edin H.M. (2006) Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in two European countries: a cross-sectional patient survey. Journal of Clinical Psychiatry 67: 204 - 210
22. Zajecka J. (2001) Strategies for the treatment of antidepressant-related sexual dysfunction. Journal of Clinical Psychiatry 62 (Suppl 3). 35 - 43